Colon cancer and normal cell lines



Similar documents
Breast cancer and normal cell lines

Bone cancer and normal cell lines

Lung cancer and normal cell lines

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

T Cell Maturation,Activation and Differentiation

Practical Effusion Cytology

Malignant Lymphomas and Plasma Cell Myeloma

The Immune System: A Tutorial

Microbiology AN INTRODUCTION EIGHTH EDITION

KMS-Specialist & Customized Biosimilar Service

Endocrine Glands and the General Principles of Hormone Action

Report series: General cancer information

Immunohistochemistry. Services & Products. Indivumed GmbH Falkenried 88, Bldg. D Hamburg Germany

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

Name (print) Name (signature) Period. (Total 30 points)

Seattle. Case Presentations. Case year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

B Cell Generation, Activation & Differentiation. B cell maturation

Custom Antibody Services

Types, production of antibodies and Antibody/antigen interaction

Functions of Blood. Collects O 2 from lungs, nutrients from digestive tract, and waste products from tissues Helps maintain homeostasis

The Diagnosis of Cancer in the Pathology Laboratory

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Problem Set 6 KEY

2) Macrophages function to engulf and present antigen to other immune cells.

B cell activation and Humoral Immunity

Lab 18 The Digestive System

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy

Chapter 18: Applications of Immunology


BLOOD-Chp. Chp.. 6 What are the functions of blood? What is the composition of blood? 3 major types of plasma proteins

Immuno-Oncology Therapies to Treat Lung Cancer

Carbohydrate antigen 19 9 (CA 19 9) (serum, plasma)

NEOPLASIA (4) Tumor-Host Interactions and Systemic Effects of Neoplasms

Small & Large Intestines

Custom Antibody Services

Corporate Medical Policy Urinary Tumor Markers for Bladder Cancer

Activation and effector functions of HMI

CUSTOM ANTIBODIES. Fully customised services: rat and murine monoclonals, rat and rabbit polyclonals, antibody characterisation, antigen preparation

Chapter 43: The Immune System

targeted therapy a guide for the patient

Clinically Actionable Biomarkers in Rheumatoid Arthritis

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

Cytopathology Case Presentation #8

How To Expand Hematopoietic Stem Cells

Blood-Based Cancer Diagnostics

Chapter 18. Blood Types

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:

Recognition of T cell epitopes (Abbas Chapter 6)

Update in Hematology Oncology Targeted Therapies. Mark Holguin

T Cell Immunotherapy for Cancer

Rheumatoid arthritis: an overview. Christine Pham MD

SBH Sciences. Innovative Biotechnology Company Two Discovery Programs. Discovery and Pre-clinical Contract Research Organization

Premarital Screening Standard. Premarital Screening and Counseling Program. Version 1.1

Effusions: Mesothelioma and Metastatic Cancers

How To Test For Cancer

LAB 14 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

Figure 14.2 Overview of Innate and Adaptive Immunity

SMALL AND LARGE INTESTINE SECRETIONS

Really Good Antibodies. Secondary Antibodies. Over 670 Anti-Mouse, Rabbit, Goat and Rat Secondary Antibodies. bethyl.com

The Body s Defenses CHAPTER 24

ELISA BIO 110 Lab 1. Immunity and Disease

Immunity. Humans have three types of immunity innate, adaptive, and passive: Innate Immunity

The Use of Antibodies in Immunoassays

A23: Oncologic Disease- Tumor Markers

Exercise 9: Blood. Readings: Silverthorn 5 th ed, , ; 6 th ed, ,

Introduction to Pathology and Diagnostic Medicine

INTERPRETATION INFORMATION SHEET

CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS

Superior TrueMAB TM monoclonal antibodies for the recognition of proteins native epitopes

Immune Therapy for Pancreatic Cancer

Developments in Biomarker Identification and Validation for Lung Cancer

Reference Range: mmol/l (arterial) mmol/l (venous) CPT Code: 83605

Antibody Function & Structure

Aviva Systems Biology

Reproductive System & Development: Practice Questions #1

Human CD4+T Cell Care Manual

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE

NM- Nuclear Medicine

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein

Welcome to Mini Med School at the Child & Family Research Institute

THE GI TRACT IS A CONTINUOUS MULTILAYERED TUBE EXTENDING FROM THE MOUTH TO THE ANUS THAT IS SUPPORTED AND PARTIALLY COVERED BY THE PERITONEUM.

WHOLE BLOOD LYSING SOLUTION FOR FLOW CYTOMETRIC APPLICATIONS

Too Many B Cells: Chronic Lymphocytic Leukemia and the Role of Flow Cytometry

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

Chapter 16: Innate Immunity

TABLE OF CONTENT. Page ACKNOWLEDGEMENTS. iii ENGLISH ABSTRACT THAI ABSTRACT. vii LIST OF TABLES LIST OF FIGURES. xvi ABBREVIATIONS.

37 2 Blood and the Lymphatic System Slide 1 of 34

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères Evry Cedex. is involved at each stage of your project

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Targeted Therapies in Lung Cancer

Human Anatomy & Physiology I with Dr. Hubley. Practice Exam 1

Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions

The Lymphatic System. Dr. Naim Kittana, PhD

Blood, Lymphatic and Immune Systems

MHC (MAJOR HISTOCOMPATIBILITY COMPLEX)

Transcription:

The Essentials of Life Science Research Globally Delivered Colon cancer and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-2577 RKO Carcinoma CRL-2579 RKO-AS45-1 Carcinoma HTB-38 HT-29 CCL-238 SW1417 [SW-1417] CCL-237 SW948 [SW-948] CCL-221 DLD-1 epithelial CCL-228 SW480 [SW-480] grade III, grade III, Dukes' type B, 44 years Caucasian 53 years Caucasian 81 years Caucasian 50 years Caucasian p53 + (wild type) p53 + (underexpressed) secretory component of IgA; carcinoembryonic antigen (CEA); transforming growth factor beta binding protein; mucin, myc +; ras +; myb +; fos +; sis +; p53 +; abl -; ros -; src -, Blood Type A; Rh+; HLA A1, A3, B12, B17, Cw5, HT-29 cells are negative for CD4, but there is cell surface expression of galactose ceramide (a possible alternative receptor for HIV). carcinoembryonic antigen (CEA) 362 ng/10 exp6 cells/10 days; keratin, myc +; ras +; fos +; sis +; p53 -; myb -; abl -; ros -; src -, blood type B; Rh+, The cells are positive for keratin by immunoperoxidase staining., The line is positive for expression of c-myc, H-ras, sis and fos oncogenes. carcinoembryonic antigen (CEA) 7 ng/10 exp6 cells/10 days; specific antigen (CSAp) 750 units in 0.5 ml cell sonicate; keratin, myc +; myb +; ras +; fos +; p53 +; sis -; abl -; ros -; src -, blood type O; Rh+, The cells are positive for keratin by immunoperoxidase staining., The line is positive for expression of c-myc, K-ras, H-ras, N-ras, myb and fos oncogenes. carcinoembryonic antigen (CEA) 0.5 ng/10 exp6 cells/10 days; antigen 3; keratin, myc +; myb + ; ras +; fos +; sis +; p53 +; abl -; ros -; src -, blood type O, DLD-1 cells are positive for p53 antigen expression (the p53 antigen produced has a C -> T mutation resulting in Ser -> Phe at position 241)., The cells are positive for keratin by immunoperoxidase staining., The line is positive for expression of c-myc, K-ras, H-ras, N-ras, myb, sis and fos oncogenes. carcinoembryonic antigen (CEA) 0.7 ng/10 exp6 cells/10 days; keratin; transforming growth factor beta, myc +; myb + ; ras +; fos +; sis +; p53 +; abl -; ros -; src -, HLA A2, B8, B17; blood type A; Rh+, The cells are positive for keratin by immunoperoxidase staining., The line is positive for expression of c-myc, K-ras, H-ras, N-ras, myb, sis and fos oncogenes.

CCL-233 SW1116 [SW 1116, SW-1116] CL-188 LS 174T CCL-218 WiDr CCL-220 COLO 320DM CCL-220.1 COLO 320HSR [COLO 320 HSR] CCL-225 HCT-15 CCL-230 SW403 [SW-403] CCL-231 SW48 [SW-48] CCL-244 HCT-8 [HRT-18] Dukes' type A, grade III, Dukes' type B, grade III, grade IV, ileocecal CCL-247 HCT 116 carcinoma CCL-255 LS123 Epithelial CL-187 LS 180 Dukes' type B, Dukes' type B, CRL-12011 HX [HT1080 xeno] fibrosarcoma CRL-12012 HP [HT1080 poly] fibrosarcoma CRL-1459 CCD-18Co normal CRL-1539 CCD-33Co CRL-1541 CCD-112CoN CRL-1790 CCD 841 CoN epithelial 73 years Caucasian 58 years Caucasian 55 years Caucasian 55 years Caucasian 51 years Caucasian 82 years Caucasian 67 years carcinoembryonic antigen (CEA) 2654 ng/10 exp6 cells/10 days; keratin, myc +; myb + ; ras +; fos +; sis +; p53 +; abl -; ros -; src -, blood type O; Rh+, The cells are positive for keratin by immunoperoxidase staining., The line is positive for expression of c-myc, K-ras, H-ras, myb, sis and fos oncogenes. carcinoembryonic antigen (CEA), interleukin 10 (IL-10), interleukin 6 (IL-6), mucin, myc +; myb + ; ras +; fos +; p53 +; sis -; abl -; ros -; src -, serologically defined cancer antigen 3;, expressed, HLA A2, B13, B50; Blood type O, The line is positive for expression of c-myc, N-myc, H-ras, N-ras. serotonin; norepinephrine; epinephrine; adrenocorticotropic hormone (ACTH); parathyroid hormone serotonin; norepinephrine; epinephrine; adrenocorticotropic hormone (ACTH); parathyroid hormone carcinoembryonic antigen (CEA) 5.4 ng/10<sup>6</sup> cells/10 days. The cells are positive for keratin by immunoperoxidase staining. carcinoembryonic antigen (CEA) 155 ng/10 exp6 cells/10 days; keratin, blood type O, The cells are positive for keratin by immunoperoxidase staining. carcinoembryonic antigen (CEA) 0.6 ng/10 exp6 cells/10 days; keratin, HLA A32, A33, B27, B35; blood type AB; Rh+, The cells are positive for keratin by immunoperoxidase staining. carcinoembryonic antigen (CEA) 0.5 ng/10 exp6 cells/10 days; alkaline phosphatase; keratin, The cells are positive for keratin by immunoperoxidase staining. carcinoembryonic antigen (CEA) 1 ng per 10<sup>6</sup> cells per 10 days. 65 years Caucasian carcinoembryonic antigen (CEA), 9 ng/ml per 10 exp6 cells per 10 days; mucin 58 years Caucasian 35 years Caucasian 35 years Caucasian 2.5 months Black 7 years Caucasian 22 weeks 21 weeks fetus carcinoembryonic antigen, interleukin 10, interleukin 6, mucin, HLA A2, B13, B50; Blood type O, serologically defined cancer antigen 3;, expressed 2 Order online at www.atcc.org, call 800.638.6597, 703.365.2700, or contact your local distributor.

CRL-1807 CCD 841 CoTr CRL-1831 FHC Epithelial CRL-1923 Ramos.2G6.4C10 B CRL-2102 C2BBe1 [clone of Caco-2 (ATCC HTB-37)] Enterocyte Burkitt's lymphoma (American) CRL-2578 RKO-E6 Carcinoma, Papilloma, CRL-2780 ATRFLOX [Mutatect] epithelial carcinoma CRL-7213 Hs 255.T CRL-7214 Hs 257.T CRL-7400 Hs 675.T cancer HTB-37 Caco-2 Epithelial HTB-39 SK-CO-1 : ascites CCL-224 COLO 201 : ascites CCL-222 COLO 205 : ascites CRL-7435 Hs 698.T CCL-229 LoVo : connective tissue : left supraclavicular region Dukes' type D, Dukes' type D, grade IV, CCL-248 T84 : lung carcinoma CCL-227 CRL-5972 SW620 [SW-620] SNU-C1 : lymph node : peritoneum 21 weeks 13 weeks 3 years Caucasian immunoglobulin (surface and secreted), CD23 + 72 years Caucasian 46 years Caucasian 71 years Caucasian 72 years Caucasian 65 years Caucasian ataxia telangiectasia and Rad3 related Caucasian keratin, retinoic acid binding protein 1, retinol binding protein 2 myc +; ras +; myb +; fos +; sis +; p53 +; abl -; ros -; src -, Blood Type O; Rh+; HLA A1, A3, B7, B13 70 years Caucasian myc +; ras + ; myb + ; fos +; sis +; p53 +; abl -; ros -; src - 70 years Caucasian 70 years 56 years 72 years American Indian 51 years Caucasian 71 years Asian carcinoembryonic antigen (CEA) 1.5 to 4.1 ng/10 exp6 cells/10 days; keratin; interleukin 10 (IL-10, interleukin-10), The cells are positive for keratin by immunoperoxidase staining. carcinoembryonic antigen (CEA) 908 ng/10 exp6 cells/10 days, myc +; myb + ; ras +; fos +; p53 +; sis -; abl -; ros -; src -, HLA A11, B15, B17, Cw1, Cw3; blood type B, The cells are negative for expression of CSAp (CSAp-) and antigen 3., The line is positive for expression of c-myc, K-ras, H-ras, N-ras, Myb, sis and fos oncogenes. carcinoembryonic antigen (CEA), 600 ng/ml per 10 exp6 cells per 10 days; keratin, The cells are positive for keratin by immunoperoxidase staining. carcinoembryonic antigen (CEA) 0.15 ng/10 exp6 cells/10 days; transforming growth factor alpha; keratin; matrilysin, myc +; myb + ; ras +; fos +; sis +; p53 +; abl -; ros -; src -, blood type A; Rh+, The cells are negative for expression of CSAp (CSAp-) and antigen 3, negative., The cells are positive for keratin by immunoperoxidase staining., The line is positive for expression of c-myc, K-ras, H-ras, N-ras, Myb, sis and fos oncogenes. Order online at www.atcc.org, call 800.638.6597, 703.365.2700, or contact your local distributor. 3

CL-177 XB-2 epithelial keratinocyte teratoma CRL-1838 M-NFS-60 virus induced myelogenous leukemia CRL-2638 CT26.WT Carcinoma CRL-2639 CT26.CL25 Carcinoma, Leukemia HB-8240 HB-8248 HB-8247 CLT 85 [SKI 294/CLT 85] HT 29/36 [SKI 294/HT 29/36] HT 29/26 [SKI 294/HT 29/26],, Tissue,, Tissue, intestine, Tissue,, CRL-8019 1116NS-3d, spleen HB-12314 PCA 31.1, spleen HB-12315 PCA 33.28, spleen HB-8059 1116-NS-19-9, spleen HB-9397 HB-8244 7E12H12 CLT 152 [SKI 294/CLT 152], spleen,, Epithelium, Tissue Cancer, Adenocarcinoma, Cancer Cancer, Adenocarcinoma, Cancer Cancer, Cancer Adenocarcinoma Carcinoma, Carcinoma Carcinoma, Carcinoma Carcinoma, Cancer Cancer, Cancer CRL-10632 TAC-1 fibroblast CCL-242 GPC-16 Saguinus oedipus Cavia porcellus 6 years old H-2d beta galactosidase (beta-gal), H-2d, The lethal subclone CT26.CL25 (ATCC CRL-2639) was selected for use in all in vitro and in vivo studies because of its stable high expression of both beta-gal and the class I molecule H-2 Ld. immunoglobulin; monoclonal antibody; against human immunoglobulin; monoclonal antibody; against human immunoglobulin; monoclonal antibody; against a 29000 dalton glycoprotein (gp29) expressed in human cells immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA) immunoglobulin; monoclonal antibody; against human carcinoma associated antigens (CCAA) immunoglobulin; monoclonal antibody; against human carcinoma associated antigens (CCAA) immunoglobulin; monoclonal antibody; against carcinoma monosialoganglioside immunoglobulin; monoclonal antibody; against human 40 kda ic protein immunoglobulin; monoclonal antibody; against a 52000 dalton protein expressed in human epithelial cells of the gastrointestinal tract mucosa (stomach, small intestine, esophagus and ) keratin, The cells are positive for keratin by immunoperoxidase staining. 4 Order online at www.atcc.org, call 800.638.6597, 703.365.2700, or contact your local distributor.

PHONE 800.638.6597 703.365.2700 EMAIL tech@atcc.org WEB www.atcc.org CB-0513-01 2013 American Type Culture Collection. The ATCC trademark and trade name, any and all ATCC catalog numbers and any other trademarks listed in this publication are trademarks of the American Type Culture Collection unless indicated otherwise. These products are for laboratory use only. Not for human or diagnostic use. ATCC products may not be resold, modified for resale, used to provide commercial services or to manufacture commercial products without prior ATCC written approval.